Jian Irish, PhD, MBA

Jian Irish has over 25 years of lead­er­ship expe­ri­ence in the bio­phar­ma oper­a­tions, with exec­u­tive respon­si­bil­i­ties in drug devel­op­ment and com­mer­cial­iza­tion, orga­ni­za­tion build­ing, and glob­al busi­ness operations.

President & Chief Operating Officer

Most recent­ly, Jian served in exec­u­tive lead­er­ship roles launch­ing one of the first approved CAR‑T cell ther­a­py prod­ucts and scal­ing out cell ther­a­py oper­a­tions at Kite Phar­ma as Senior Vice Pres­i­dent, Glob­al head of Man­u­fac­tur­ing, and Senior Vice Pres­i­dent of Sup­ply Chain.

Pri­or to Kite, Jian was Vice Pres­i­dent for bio­log­ics prod­uct devel­op­ment, sup­ply, and part­ner­ships at Sanofi. Jian also served in exec­u­tive lead­er­ship roles at Amgen in the oncol­o­gy devel­op­ment, man­u­fac­tur­ing, and JAPAC region­al oper­a­tions, con­tribut­ing to the launch of many inno­v­a­tive med­i­cines in her tenure of 15 years at Amgen.

Jian holds a PhD in Phar­ma­ceu­ti­cal Sci­ences from Chi­ba Uni­ver­si­ty in Japan and a BS in Chem­i­cal Engi­neer­ing from East Chi­na Uni­ver­si­ty of Sci­ence and Tech­nol­o­gy, as well as an MBA from the Ander­son School of Man­age­ment at UCLA.